A recent study found treatment of systemic disease is a major factor influencing survival in patients with breast cancer that has metastasized to the brain.
The researchers’ finding suggests the possibility of designing pharmaceutical or genetic therapies to turn on new neuron production in old or injured brains.
Robert F. Kennedy Jr., best known for public health conspiracy theories and misinformation, doesn’t have much of a record on the rest of healthcare.
A 65-year-old woman had transitory visual aura in her left eye as well as total loss of vision lasting about 30 minutes. This case illustrates…
In this episode, hosts explore the most recent updates surrounding GLP-1 receptor agonists, including GLP-1 shortages and long-term data on tirzepatide.
People who contracted COVID-19 during the early stages of the pandemic had an increased risk of myocardial infarction (heart attack), stroke, and death for the…
Eyenovia said on Friday it will discontinue a late-stage study for its experimental drug-device combination to treat near-sightedness and cut about 50% of its workforce.
This surgical procedure is considered when medication is no longer adequate in maintaining the quality of life for patients struggling with neurological conditions.
The ongoing threat of cyber attacks in maritime global trade
A palliative medicine specialist explains how to put HER2-low metastatic breast cancer resources to use.
